LYNNE BENJAMIN: Open Payments
NPI 1134528946 · AVON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 15 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $150 |
| PFIZER INC. | 3 | $66 |
| Sumitomo Pharma America, Inc. | 2 | $56 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Novo Nordisk Inc | 1 | $26 |
| Lilly USA, LLC | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Lundbeck LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: REZDIFFRA, GEMTESA, Rybelsus, TRELEGY ELLIPTA, VYNDAQEL, PAXLOVID, MOUNJARO, AIRSUPRA.
Industry payments across CT — which companies pay providers there.
